Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance

Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance Here we report the presence of hyperphagia, obesity and insulin resistance in knockout mice deficient in IL-18 or IL-18 receptor, and in mice transgenic for expression of IL-18 binding protein. Obesity of Il18 −/− mice resulted from accumulation of fat tissue based on increased food intake. Il18 −/− mice also had hyperinsulinemia, consistent with insulin resistance and hyperglycemia. Insulin resistance was secondary to obesity induced by increased food intake and occurred at the liver level as well as at the muscle and fat-tissue level. The molecular mechanisms responsible for the hepatic insulin resistance in the Il18 −/− mice involved an enhanced expression of genes associated with gluconeogenesis in the liver of Il18 −/− mice, resulting from defective phosphorylation of STAT3. Recombinant IL-18 (rIL-18) administered intracerebrally inhibited food intake. In addition, rIL-18 reversed hyperglycemia in Il18 −/− mice through activation of STAT3 phosphorylation. These findings indicate a new role of IL-18 in the homeostasis of energy intake and insulin sensitivity. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nature Medicine Springer Journals

Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance

Download PDF
7 pages

Loading next page...
 
/lp/springer-journals/deficiency-of-interleukin-18-in-mice-leads-to-hyperphagia-obesity-and-gukhqz0iol

References (27)

Publisher
Springer Journals
Copyright
Copyright © 2006 by Nature Publishing Group
Subject
Biomedicine; Biomedicine, general; Cancer Research; Metabolic Diseases; Infectious Diseases; Molecular Medicine; Neurosciences
ISSN
1078-8956
eISSN
1546-170X
DOI
10.1038/nm1415
Publisher site
See Article on Publisher Site

Abstract

Here we report the presence of hyperphagia, obesity and insulin resistance in knockout mice deficient in IL-18 or IL-18 receptor, and in mice transgenic for expression of IL-18 binding protein. Obesity of Il18 −/− mice resulted from accumulation of fat tissue based on increased food intake. Il18 −/− mice also had hyperinsulinemia, consistent with insulin resistance and hyperglycemia. Insulin resistance was secondary to obesity induced by increased food intake and occurred at the liver level as well as at the muscle and fat-tissue level. The molecular mechanisms responsible for the hepatic insulin resistance in the Il18 −/− mice involved an enhanced expression of genes associated with gluconeogenesis in the liver of Il18 −/− mice, resulting from defective phosphorylation of STAT3. Recombinant IL-18 (rIL-18) administered intracerebrally inhibited food intake. In addition, rIL-18 reversed hyperglycemia in Il18 −/− mice through activation of STAT3 phosphorylation. These findings indicate a new role of IL-18 in the homeostasis of energy intake and insulin sensitivity.

Journal

Nature Medicine – Springer Journals

Published: May 28, 2006

There are no references for this article.